Preview

Healthcare

Advanced search

Structural and functional changes in coronary arteries in chronic isoproterenol-induced cardiac ischemia

Abstract

Objective. To study the nature and sequence of development of pathomorphological processes in rat coronary arteries at different stages of modeling chronic cardiac ischemia.
Materials and methods. Chronic heart failure of ischemic genesis in Wistar rats was modeled by subcutaneous administration of β-adrenomimetic isoproterenol hydrochloride at a dose of 10 mg/kg/day for 14 days. In 4, 6 and 8 weeks after the last injection in experimental animals the features of morphofunctional changes in coronary vessels and the dynamics of changes in the activity of enzymes of cellular energy metabolism were analyzed.
Results. During the development of chronic isoproterenol-induced ischemic myocardial damage (from the 4th to the 8th week of the experiment), progression of structural changes in the vascular walls of rat coronary arteries was observed: both intima (deendothelialization and desquamation of endotheliocytes, focal subendothelial edema, disruption of the integrity of the outer and inner elastic membranes) and media and adventitia (dystrophy and necrobiosis of smooth muscle cells, loosening, edema, disorganization of layers, fibrosis) in combination with increasing sclerotic changes of perivascular spaces. Histochemical changes in endothelial cells of rat coronary vessels are manifested by a compensatory increase in lactate dehydrogenase activity by the 4th week of the experiment with a subsequent decrease in succinate and lactate dehydrogenase activity from the 6th to the 8th week of the experiment.
Conclusion. The morphological changes in rat coronary arteries have been revealed, which illustrate the dynamics of development of structural and functional changes in vessels in chronic isoproterenol-induced cardiac ischemia at late stages of its development. Structural changes in vascular walls are combined with a decrease in the efficiency of both aerobic and anaerobic pathways of energy formation.

About the Authors

Е. Fiodorova
Институт физиологии Национальной академии наук Беларуси
Belarus


S. Novakovskaya
Институт физиологии Национальной академии наук Беларуси
Belarus


А.-М. Yerofeyeva
Институт физиологии Национальной академии наук Беларуси
Belarus


А. Basalai
Институт физиологии Национальной академии наук Беларуси
Belarus


References

1. Global burden of cardiovascular diseases and risk factors, 1990—2019 : update from the GBD 2019 Study / G. A. Roth, G. A. Mensah, C. O. Johnson [et al.] // Journal of the American College of Cardiology. — 2020. — Vol. 76, № 25. — Р. 2982—3021.

2. Karbozova, A. B. The spread of circulatory system diseases worldwide / A. B. Karbozova, N. E. Glushkova // Medicine, Science and Education. — 2025. — № 1. — Р. 67—70.

3. Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction / P. Severino, A. D’Amato, M. Pucci [et al.] // International Journal of Molecular Sciences. — 2020. — Vol. 21, № 21. — DOI: 10.3390/ijms21218118.

4. Clinical significance of chronic myocardial ischemia in coronary artery disease patients / Р. С. Rezende, F. F. Ribas, C. V. Serrano Jr, W. Hueb // Journal of Thoracic Disease. — 2019. — Vol. 11, № 3. — Р. 1005—1015.

5. Yasue, H. Coronary artery spasm — clinical features, pathogenesis and treatment / H. Yasue, Y. Mizuno, E. Harada // Proceedings of the Japan Academy. Ser. В. — 2019. — Vol. 95, № 2. — Р. 53—66.

6. Bockus, L. Coronary endothelial dysfunction: from pathogenesis to clinical implications / L. Bockus, F. Kim // Open Heart. — 2022. — Vol. 9. — DOI: 10.1136/openhrt-2022-002200.

7. Buja, L. M. Pathobiology of myocardial and cardiomyocyte injury in ischemic heart disease: Perspective from seventy years of cell injury research / L. M. Buja // Experimental and Molecular Pathology. — 2024. — Vol. 140. — DOI: 10.1016/J.YEXMP.2024.104944.

8. Experimental models of cardiac physiology and pathology / J. G. Oh, Ch. Kho, R. J. Hajjar, K. Ishikawa // Heart Failure Reviews. — 2019. — Vol. 24, № 4. — Р. 601—615.

9. European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes : Explanatory report, Strasbourg, 18.03.1986 / Council of Europe. — Strasbourg : Council of Europe Publ., 1987. — European treaty series; № 123. — URL: https://rm.coe.int/168007a67b (date of access: 09.06.2025).

10. Huoxin Pill attenuates cardiac fibrosis by suppressing TGF-β1/Smad2/3 pathway in isoproterenol-induced heart failure rats / M. Peng, Mei-Ling Yang, A-Ling Shen [et al.] // Chinese Journal of Integrative Medicine. — 2021. — Vol. 27, № 6. — Р. 424—431.

11. Лойда, З. Гистохимия ферментов: лабораторные методы / З. Лойда, Р. Госсрау, Т. Шиблер. — М. : Мир, 1982. — 270 с.


Review

For citations:


Fiodorova Е., Novakovskaya S., Yerofeyeva А., Basalai А. Structural and functional changes in coronary arteries in chronic isoproterenol-induced cardiac ischemia. Healthcare. 2025;(8):46-51. (In Russ.)

Views: 10


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)